Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2019-08-29 to 2025-02-28
Current total value of award: $385920
Description: SERVICES FOR CLONOSEQ FDA-CLEARED IN-VITRO DIAGNOSTIC (IVD) TESTING.